Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Interim Report Q3 2024

Oriola will publish its Interim Report for January-September 2024 on Wednesday 30 October 2024 at around 8.30 a.m. Welcome to join our results presentation as a live webcast at 10 a.m. on the same day.

Annual Report 2023

Our Annual Report consists of the following sections: Business review, Sustainability report, Corporate governance statement, Remuneration report, Report of the Board of Directors and Financial statements.